Get Your Personalized Supplement StackSupplement Stack Quiz

Buchu Leaves

Also known as: Agathosma crenulata, Buchu leaves, Agathosma betulina

Overview

Buchu leaves are derived from two species of aromatic shrubs, Agathosma betulina and Agathosma crenulata, native to South Africa. Traditionally, they have been utilized in Khoi-San medicine, primarily for addressing urinary tract and inflammatory conditions. The leaves contain essential oils and various phytochemicals, which are believed to contribute to their purported antimicrobial, antioxidant, anti-inflammatory, and metabolic effects. While preclinical research suggests several potential benefits, human clinical trials are scarce and generally of low quality. Consequently, the overall evidence supporting the efficacy and safety of buchu leaves in humans is considered low to moderate, with a notable absence of high-quality randomized controlled trials or meta-analyses.

Benefits

Preclinical studies suggest several potential benefits for buchu leaves, though human evidence is largely lacking. Moderate antimicrobial effects have been observed in vitro for leaf extracts, indicating potential against certain pathogens, particularly relevant for urinary tract infections (UTIs). In vitro studies also show moderate antioxidant capacity and a reduction in inflammatory markers like IL-6 and TNF-α. Animal studies have indicated promising metabolic effects, including normalized glucose levels in diabetic rats, reduced weight gain and intraperitoneal fat in high-fat diet rats, and lowered elevated blood pressure. Additionally, in vitro research points to anti-inflammatory potential through the inhibition of neutrophil and monocyte respiratory burst and adhesion molecule expression. However, it is crucial to note that no robust human data currently confirm these effects or quantify their clinical benefit, and the strength of evidence for all listed benefits is low to moderate, based predominantly on preclinical findings.

How it works

The proposed mechanisms of action for buchu extracts involve several biological pathways. Their antioxidant effects are thought to contribute to cellular protection, while anti-inflammatory properties may stem from the inhibition of pro-inflammatory cytokines such as IL-6 and TNF-α. In metabolic contexts, buchu may modulate glucose uptake in adipocytes, potentially contributing to glucose regulation. However, the specific active compounds responsible for these effects have not been fully identified due to a lack of detailed phytochemical characterization in most studies. Furthermore, the bioavailability and pharmacokinetics of buchu compounds in humans are not well-studied, making it difficult to fully understand their systemic interactions.

Side effects

Buchu leaves are likely safe when consumed in typical food amounts, but their safety in medicinal doses is less certain, and high doses or ingestion of the essential oil are potentially unsafe. Common side effects reported include gastrointestinal irritation and increased menstrual flow. More serious concerns, though rare, include potential liver toxicity. Buchu is contraindicated during pregnancy due to a reported risk of miscarriage. It may also slow blood clotting, increasing the risk of bleeding, especially when combined with anticoagulant medications. Due to a lack of evidence and potential risks, buchu should be avoided in individuals with kidney infections or existing urinary tract inflammation. Caution is advised, and medical consultation is recommended before use, particularly for individuals with pre-existing conditions or those on medication.

Dosage

There are currently no established clinical dosing guidelines for buchu leaves due to the scarcity of human randomized controlled trials. Traditional use often involves aqueous leaf extracts, but the doses used in animal studies are not directly translatable to humans. Given the safety concerns, particularly regarding potential liver toxicity and bleeding risk, caution is strongly advised. Without robust human data, safe and effective dosages cannot be reliably determined. Any use of buchu as a supplement should be undertaken with extreme caution and under the guidance of a healthcare professional, who can assess individual risks and benefits. Clinical trials are urgently needed to establish appropriate and safe dosing regimens.

FAQs

Is buchu effective for UTIs?

Limited in vitro antimicrobial evidence exists, but no high-quality human trials confirm its efficacy for treating urinary tract infections.

Is it safe during pregnancy?

No, buchu is considered likely unsafe during pregnancy and has been linked to an increased risk of miscarriage.

Can it cause liver damage?

There are reports suggesting possible liver toxicity; monitoring is recommended if buchu is used medicinally, especially long-term.

Does it help with diabetes or weight loss?

Animal studies show promise for metabolic effects, including glucose normalization and weight reduction, but human evidence is currently lacking.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC8859318/ – This review of pharmacological studies on Agathosma betulina (Buchu) summarizes preclinical findings. It highlights moderate antimicrobial and antioxidant activity, as well as glucose normalization and cardioprotective effects observed in diabetic and obese rat models. The review also notes in vitro anti-inflammatory effects, but emphasizes the lack of human randomized controlled trials and the need for further research to fully characterize extract composition and validate findings in humans.
https://library.oapen.org/bitstream/id/3fb4c477-2462-4dde-9b30-5babe8775740/978-1-928396-82-6.pdf – This source, an unpublished thesis summary by Huisamen et al., presents findings from animal model studies on buchu. It indicates anti-obesity, anti-hypertensive, and cardioprotective effects in diabetic and hypertensive rat models. The summary acknowledges that the data are exclusively from animal studies, with no human data, and that the findings are from a limited peer-reviewed publication, suggesting a low quality of evidence for human application.
https://www.rxlist.com/supplements/buchu.htm – This RxList summary provides an overview of the safety profile of buchu. It states that buchu is likely safe in food amounts but highlights potential risks such as liver toxicity and increased bleeding risk. The summary also strongly contraindicates buchu use during pregnancy due to miscarriage concerns. It notes that safety concerns are primarily based on case reports rather than robust clinical trials, indicating a low to moderate quality of safety data.